Fresh Tracks Therapeutics (FRTX) Insider Trading & Ownership $0.72 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsTrends Fresh Tracks Therapeutics (NASDAQ:FRTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.23%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$39,480.00Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$97.94 Get FRTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Fresh Tracks Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address FRTX Insider Buying and Selling by Quarter Ad Porter & CompanyWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. Fresh Tracks Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/20/2023Exploration Capital, LlcMajor ShareholderBuy47,000$0.84$39,480.00 12/8/2023Aaron Fox-CollisCAOSell74$0.91$67.34 12/4/2023Aaron Fox-ColisCAOSell36$0.85$30.60 (Data available from 1/1/2013 forward) FRTX Insider Trading Activity - Frequently Asked Questions Who is on Fresh Tracks Therapeutics's Insider Roster? The list of insiders at Fresh Tracks Therapeutics includes Aaron Fox-Colis, Aaron Fox-Collis, and Exploration Capital, Llc. Learn more on insiders at FRTX. What percentage of Fresh Tracks Therapeutics stock is owned by insiders? 0.23% of Fresh Tracks Therapeutics stock is owned by insiders. Learn more on FRTX's insider holdings. Which Fresh Tracks Therapeutics insiders have been buying company stock? The following insider purchased FRTX shares in the last 24 months: Exploration Capital, Llc ($39,480.00). How much insider buying is happening at Fresh Tracks Therapeutics? Insiders have purchased a total of 47,000 FRTX shares in the last 24 months for a total of $39,480.00 bought. Which Fresh Tracks Therapeutics insiders have been selling company stock? The following insiders have sold FRTX shares in the last 24 months: Aaron Fox-Colis ($30.60), and Aaron Fox-Collis ($67.34). How much insider selling is happening at Fresh Tracks Therapeutics? Insiders have sold a total of 110 Fresh Tracks Therapeutics shares in the last 24 months for a total of $97.94 sold. Fresh Tracks Therapeutics Key ExecutivesMr. Albert Nicholas Marchio II (Age 72)CEO, CFO, Secretary & Chairman Aron Aizenstat M.B.A.P.M.P., Vice President of Corporate Development & OperationsMr. Aaron Fox-Collis CPAVP of Finance & Chief Accounting OfficerMs. Sue FattorHead of Human ResourceDr. James S. McElvain Ph.D.Interim Head of CMC Development More Insider Trading Tools from MarketBeat Related Companies Synlogic Insider Trades Talphera Insider Trades Chemomab Therapeutics Insider Trades Aspira Women's Health Insider Trades IN8bio Insider Trades Avalo Therapeutics Insider Trades Cara Therapeutics Insider Trades Biora Therapeutics Insider Trades Mannatech Insider Trades Sensei Biotherapeutics Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Big Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics PartnersInsider Selling is not a Signal to Start Selling Gartner Stock2 Stocks to Buy and 1 to Sell - Smart Moves for Investors3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside This page (NASDAQ:FRTX) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fresh Tracks Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fresh Tracks Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
